Nisa Investment Advisors, LLC Curis Inc Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$0.71 - $2.43 $43,452 - $148,716
-61,200 Closed
0 $0
Q1 2022

Apr 29, 2022
BUY
$2.31 - $5.13 $116,913 - $259,639
50,612 Added 478.01%
61,200 $146,000
Q4 2021

Feb 03, 2022
SELL
$4.45 - $8.09 $9,500 - $17,272
-2,135 Reduced 16.78%
10,588 $34,000
Q3 2021

Oct 18, 2021
BUY
$6.94 - $8.85 $88,297 - $112,598
12,723 New
12,723 $100,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email